Email this article 
Experience of lordestin (desloratadine) use in patients with seasonal allergic rhinitis
- Authors: Ilyina NI1, Pavlova KS1
-
Affiliations:
- Institute of Immunology
- Issue: Vol 9, No 1 (2012)
- Pages: 79-83
- Section: Articles
- Submitted: 10.03.2020
- Published: 15.12.2012
- URL: https://rusalljournal.ru/raj/article/view/744
- DOI: https://doi.org/10.36691/RJA744
- ID: 744
Cite item
Open Access
Access granted
Abstract
The article presents the results of the study of the Lordestin's (desloratadine) efficacy and safety in patients with seasonal allergic rhinitis. The results showed that Lordestin is highly effective in reducing of the severity of nasal and ocular symptoms in patients with hay fever, has a good safety profile and may be recommended as a monotherapy or as a component of combination therapy in patients with allergic rhinitis.
Full Text
About the authors
N I Ilyina
Institute of ImmunologyMoscow, Russia
K S Pavlova
Institute of Immunology
Email: ksenimedical@gmail.com
Moscow, Russia
References
- Гущин И.С., Ильина Н.И., Польнер С.А. Аллергический ринит (Пособие для врачей). М., 2002, 72 с.
- Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update. Allergy (Suppl.86). 2008, v. 63, p. 1-160.
- Church M.K., Maurer M., Simons F.E.R. et al. Risk of firstgeneration H,-antihistamines: a GA2LEN position paper. Allergy. 2010, v. 65, No. 4, p. 459-466.
- Павлова К.С., Курбачева О.М., Ильина Н.И. Новый способ оценки клинической эффективности антигиста-минных препаратов при лечении поллиноза. Аллергия, астма и клин. иммунол. 2003, № 12, с. 3-8.
Supplementary files
